RPS3A (NP_000997, 164 a.a. ~ 263 a.a) partial recombinant protein with GST tag. The sequence is IRKKMMEIMTREVQTNDLKEVVNKLIPDSIGKDIEKACQSIYPLHDVFVRKVKMLKKPKF ELGKLMELHGEGSSSGKATGDETGAKVERADGYEPPVQES
Conjugate
Unconjugated
Target
Alternative Names
RPS3A; ribosomal protein S3A; S3A; FTE1; MFTL; 40S ribosomal protein S3a; fte-1; v-fos transformation effector protein 1;
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 40S subunit. The protein belongs to the S3AE family of ribosomal proteins. It is located in the cytoplasm. Disruption of the gene encoding rat ribosomal protein S3a, also named v-fos transformation effector protein, in v-fos-transformed rat cells results in reversion of the transformed phenotype. This gene is co-transcribed with the U73A and U73B small nucleolar RNA genes, which are located in its fourth and third introns, respectively. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Alternatively spliced transcript variants have been found for this gene.
Pathway
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S; Cytoplasmic Ribosomal Proteins; Eukaryotic Translation Elongation; Eukaryotic Translation Termination
Citations
Publication ()
Have you cited DPAB-DC2742 in a publication? Let us know and earn a reward for your research.
My Review for Anti-RPS3A (aa 164-263) polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.